Nitroglycerin to Facilitate Radial Arterial Catheter Insertion in Children

December 10, 2019 updated by: Ahmed Hasanin, Cairo University

Topical Nitroglycerin to Facilitate Radial Arterial Catheter Insertion in Children: a Randomized Controlled Study

Local nitroglycerin (NTG) was successfully used as a vasodilator to facilitate cannulation of the radial artery. NTG was used in adults by topical application as well as subcutaneous infiltration. Subcutaneous infiltration of NTG resulted in significant vasodilatation, improved palpability of the radial artery, reduced the number of punctures and the time needed for cannulation in adults. Topical NTG was reported to increase radial artery diameter in healthy volunteers without reduction in arterial blood pressure. In pediatric population, there no sufficient evidence for the effectiveness of NTG in improving radial artery cannulation. In a case report on two neonates, topical nitroderm ointment successfully reversed tissue ischemia secondary to radial artery cannulation The aim of this work is to evaluate the use of topical NTG (patch) for increasing the diameter of radial artery, improving the cannulation success, and decreasing catheter-related ischemic complications.

Study Overview

Status

Completed

Detailed Description

A written informed consent will be obtained from patient's parents or guardians. Randomization will be obtained using computer-generated sequence. Concealment will be obtained using opaque envelopes.

On arrival to the preparing room, patients will be randomized into one of the two groups:

- NTG group or, Control group

Ultrasound examination:

The diameter of radial artery will be measured using a linear, high frequency probe (12 mHz) of Simens machine. Measurement will be obtained in the short axis plane at the point with maximal pulsation. The point will be marked to guide the post-intervention examination. The operator will be an experienced single operator blinded to the study group. Measurements will be obtained in both limbs at baseline (before application of NTG patch application,30 minutes,60minutes after NTG application After induction of anesthesia, radial artery will be punctured by 22-g catheter by an experienced anesthetist

Study Type

Interventional

Enrollment (Actual)

40

Phase

  • Phase 4

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Cairo, Egypt, 11432
        • Ahmed Mohamed Hasanin

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

2 years to 5 years (Child)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • children aged between 2 and 5 years scheduled for cardiac surgery

Exclusion Criteria:

  • Systolic blood pressure less than 90 mmHg,
  • previous radial artery puncture
  • abnormal Allen's test
  • hypercoagulable states
  • coagulopathy
  • previous vascular complications

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Quadruple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: NTG group
In this group, nitroglycerin patch will be applied near the radial artery pulsation covered with a gauze.
A half-NTG patch (dose calculated at 5-12.5 mcg/kg/hr) will be applied to patients at the site of radial pulsation one hour before induction of anesthesia. The NTG patch will be applied to the right upper in half of the patients and will be applied to the left upper limb in the other half
A gauze will be applied near the radial artery pulsation to ensure blinding
Placebo Comparator: Control group
In this group, no patch as applied to the patient. However, a gauze will be applied to confirm blinding
A gauze will be applied near the radial artery pulsation to ensure blinding

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
change in The diameter of radial artery
Time Frame: 1 minutes before intervention then 30 and 60-minutes after the intervention
mm
1 minutes before intervention then 30 and 60-minutes after the intervention

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
palpability of radial pulse after NTG patch application
Time Frame: 1 minutes before intervention then 30 and 60-minutes after the intervention
Grade 0: palpability did not change after NTG, grade 1: palpability improved after NTG, grade 2: palpability became bounding after NTG
1 minutes before intervention then 30 and 60-minutes after the intervention
Number of arterial punctures
Time Frame: 30 minutes
number
30 minutes
successful cannulation confirmed
Time Frame: 30 minutes
incidence
30 minutes
successful first-puncture cannulation
Time Frame: 30 minutes
incidence
30 minutes
postoperative ischemic complications
Time Frame: 24 hours post intervention
incidence
24 hours post intervention
systolic blood pressure
Time Frame: 1 minute before the intervention, every 5 minutes for 1 hour
mmHg
1 minute before the intervention, every 5 minutes for 1 hour

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Ashraf Rady, Professor, Head of department of anesthesia, Cairo University, Egypt

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 15, 2019

Primary Completion (Actual)

November 15, 2019

Study Completion (Actual)

November 30, 2019

Study Registration Dates

First Submitted

June 26, 2019

First Submitted That Met QC Criteria

June 27, 2019

First Posted (Actual)

June 28, 2019

Study Record Updates

Last Update Posted (Actual)

December 11, 2019

Last Update Submitted That Met QC Criteria

December 10, 2019

Last Verified

December 1, 2019

More Information

Terms related to this study

Other Study ID Numbers

  • S72019

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Radial Artery Canulation

Clinical Trials on NTG patch

3
Subscribe